EUVIMEDEUVIMED entdecken
Crossref

Effect of COVID-19 Vaccination on Thyroid Disease in 7 Million Adult and 0.2 Million Adolescent Vaccine Recipients

Sungho Bea iD, Hwa Young Ahn iD, Jieun Woo, Ju-Young Shin iD, Sun Wook Cho iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae858 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Sungho Bea und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea. Hauptthemen laut MEDLINE: Thyroid Diseases, COVID-19 Vaccines, COVID-19, Vaccination. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Seoul National University Hospital Research Fund, Ministry of Food and Drug Safety, South Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Emerging reports have raised concerns regarding the potential association between COVID-19 vaccination and thyroid dysfunction, specifically thyroiditis.

Objective

This study aimed to investigate the potential association between COVID-19 vaccination and thyroid diseases using data from a nationwide cohort of South Korea.

Methods

This study included 7 579 210 adult and 241 063 adolescent vaccine recipients. A self-controlled case series design was applied to estimate the incidence rate ratio (IRR) of thyroid disease during the 55-day postvaccination period (first and second dose) compared to the baseline period (nonexposure period) using conditional Poisson regression.

Results

In the adult population, IRRs for hyperthyroidism, hypothyroidism, subacute thyroiditis, and thyroid eye disease were 0.98 (95% CI, 0.89–1.09), 0.88 (95% CI, 0.84-0.93), 1.27 (95% CI, 0.94-1.72), and 0.68 (95% CI, 0.50-0.93) after the first vaccine dose and 0.96 (95% CI, 0.87-1.06), 0.96 (95% CI, 0.92-1.02), 1.32 (95% CI, 0.96-1.80), and 1.06 (95% CI, 0.81-1.38) after the second vaccine dose. While the risk of hyperthyroidism recurrence did not increase after vaccination, we observed an increased risk of hypothyroidism exacerbation. Subgroup analyses based on age, sex, and vaccine type revealed no significant differences in the incidence of thyroid diseases. In adolescents aged 12 to 17 years, no increase in the risk of thyroid disease was observed after vaccination.

Conclusion

This extensive, national self-controlled case series analysis found an increased risk of exacerbation of hypothyroidism following COVID-19 vaccination. However, no association was observed between COVID-19 vaccination and an increased risk of most other thyroid diseases. These findings contribute to increasing evidence supporting the safety of COVID-19 vaccination in relation to thyroid health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid DiseasesCOVID-19 VaccinesCOVID-19VaccinationHumansAdolescentMaleFemaleRepublic of KoreaAdultMiddle AgedYoung AdultIncidenceChildSARS-CoV-2Aged

Stichwörter der Autor:innen

COVID-19 vaccinationhyperthyroidismhypothyroidismmRNA vaccinesubacute thyroiditisthyroid dysfunction

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
  • Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02120, USA.
  • Department of Internal Medicine, Chung-ang University College of Medicine, Seoul 06973, Republic of Korea.
  • Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon 16419, Republic of Korea.
  • Department of Internal Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
  • Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea.

ORCID-Profile: Sungho Bea, Hwa Young Ahn, Ju-Young Shin, Sun Wook Cho

Förderung

  • Seoul National University Hospital Research Fund
  • Ministry of Food and Drug Safety, South Korea

Zitieren

APA

Bea, S., Ahn, H. Y., Woo, J., Shin, J. Y., & Cho, S. W. (2025). Effect of COVID-19 Vaccination on Thyroid Disease in 7 Million Adult and 0.2 Million Adolescent Vaccine Recipients. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae858

Vancouver

Bea S, Ahn HY, Woo J, Shin JY, Cho SW. Effect of COVID-19 Vaccination on Thyroid Disease in 7 Million Adult and 0.2 Million Adolescent Vaccine Recipients. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae858

BibTeX
@article{Bea2025,
  author = {Bea, Sungho and Ahn, Hwa Young and Woo, Jieun and Shin, Ju-Young and Cho, Sun Wook},
  title = {Effect of COVID-19 Vaccination on Thyroid Disease in 7 Million Adult and 0.2 Million Adolescent Vaccine Recipients},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae858}
}
Kostenlos starten →